An expert discusses how the treatment landscape for lower-risk MDS has evolved with multiple new options including luspatercept, imetelstat, and lenalidomide based on specific patient characteristics ...

Researchers are developing AI programmes to make doping detection more effective, faster, and cheaper. How do these systems ...

The global erythropoietin drugs market was valued at approximately USD 6.87 billion in 2022 and is projected to grow at a healthy growth rate of around 1.5% during the forecast period from 2023 to ...

Low levels of erythropoietin (EPO), a substance in the blood that stimulates red blood cell production in preterm infants, provide a rationale for the use of EPO to prevent or treat anaemia. A total ...

Erythropoietin reduces infarct size, but it also carries some potentially adverse affects. How can you effectively administer this drug to improve the prognosis of heart disease patients?

In contrast to the recently reported studies of Epo in patients hospitalized in intensive care units focusing on those with trauma, [60] our study was designed to minimize the risk of Epo-induced ...

We hypothesized that cord blood erythropoietin (EPO), a marker of fetal hypoxia, relates to gestational factors and not solely those associated with delivery. We investigated the association ...

Two positives, two sporting careers abruptly halted due to the use of prohibited substances, and two sanctions for crossing the red line. The ...

Introduction Erythropoietin (EPO) is a glycoprotein hormone responsible for the regulation of red blood cell production. This hormone triggers the proliferation, differentiation and maturation of bone ...

The Renal Patients Association Ghana has appealed to government to subsidise or fully absorb the cost of Erythropoietin (EPO) and iron essentials for kidney patients undergoing dialysis under the ...